Insider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 5,995 Shares of Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Nitin Kaushal sold 5,995 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $8.58, for a total transaction of $51,437.10. Following the completion of the sale, the director now owns 126,843 shares in the company, valued at $1,088,312.94. This represents a 4.51 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Nitin Kaushal also recently made the following trade(s):

• On Monday, November 11th, Nitin Kaushal sold 30,000 shares of Viemed Healthcare stock. The stock was sold at an average price of $9.56, for a total transaction of $286,800.00.

Viemed Healthcare Stock Down 1.2 %

Shares of NASDAQ VMD opened at $8.56 on Friday. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. Viemed Healthcare, Inc. has a 12-month low of $6.21 and a 12-month high of $10.44. The firm’s 50-day moving average price is $8.58 and its 200-day moving average price is $7.59. The stock has a market capitalization of $333.33 million, a price-to-earnings ratio of 31.70 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. The business had revenue of $58.00 million for the quarter. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%.

Institutional Trading of Viemed Healthcare

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its stake in shares of Viemed Healthcare by 53.0% in the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after acquiring an additional 617,009 shares during the period. Apis Capital Advisors LLC grew its holdings in Viemed Healthcare by 193.0% during the 2nd quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock valued at $1,535,000 after purchasing an additional 154,400 shares during the last quarter. Russell Investments Group Ltd. raised its position in Viemed Healthcare by 5.3% in the 1st quarter. Russell Investments Group Ltd. now owns 146,952 shares of the company’s stock worth $1,386,000 after purchasing an additional 7,386 shares during the period. Price T Rowe Associates Inc. MD bought a new stake in Viemed Healthcare in the first quarter worth about $97,000. Finally, Oppenheimer Asset Management Inc. boosted its position in shares of Viemed Healthcare by 5.6% during the third quarter. Oppenheimer Asset Management Inc. now owns 30,222 shares of the company’s stock valued at $222,000 after buying an additional 1,601 shares during the period. 74.24% of the stock is currently owned by institutional investors.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.